Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 349 | 349 | 220 | 0 | 0 |
| Gross Profit | 349 | 349 | 220 | N/A | N/A |
| Operating Expenses | 3,212 | 3,063 | 2,802 | 2,526 | 2,070 |
| Operating Income | -2,863 | -2,714 | -2,582 | -2,526 | -2,070 |
| Interest Expense | 346 | 286 | 1,635 | 198 | 151 |
| Other Income | -2,515 | 3 | 40 | 690 | -137 |
| Pre-tax Income | -5,724 | -2,996 | -4,178 | -2,034 | -2,358 |
| Net Income Continuous | -5,724 | -2,996 | -4,178 | -2,034 | -2,358 |
| Net Income | $-5,724 | $-2,996 | $-4,178 | $-2,034 | $-2,358 |
| EPS Basic Total Ops | -32.30 | -30.64 | -48.03 | -28.99 | -33.13 |
| EPS Basic Continuous Ops | -32.20 | -31.05 | -47.79 | -28.73 | -33.89 |
| EPS Diluted Total Ops | -32.30 | -30.64 | -48.03 | -28.99 | -33.13 |
| EPS Diluted Continuous Ops | -32.20 | -31.05 | -47.79 | -28.73 | -33.89 |
| EBITDA(a) | $-2,516 | $-2,434 | $-1,213 | $-2,344 | $-1,929 |